High Serum OX40 and OX40 Ligand (OX40L) Levels Correlate with Reduced Survival in Patients with Advanced Lung Adenocarcinoma.

Kashima, Jumpei; Okuma, Yusuke; Hosomi, Yukio; Hishima, Tsunekazu

Kashima, Jumpei; Okuma, Yusuke; Hosomi, Yukio; Hishima, Tsunekazu.

Affiliation

Kashima J; Department of Pathology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Okuma Y; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Hosomi Y; Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan, yokuma@ncc.go.jp.
Hishima T; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan, yokuma@ncc.go.jp.

Oncology ; 98(5): 303-310, 2020.

Article in En | MEDLINE | ID: mdl-32097938

Subject(s)

Adenocarcinoma of Lung/blood; Adenocarcinoma of Lung/mortality; Lung Neoplasms/blood; Lung Neoplasms/mortality; OX40 Ligand/blood; Receptors, OX40/blood; Aged; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Retrospective Studies

Key words

Immune exhaustion; Immunotherapy; Lung cancer; OX40; OX40 ligand

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: OX40 Ligand / Receptors, OX40 / Adenocarcinoma of Lung / Lung Neoplasms Type of study: Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Male Language: En Journal: Oncology Year: 2020 Document type: Article Affiliation country: Japan

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google